Co-resistance: An opportunity for the bacteria and resistance genes

Current Opinion in Pharmacology

Volumn 11, Issue 5, 2011, Pages 477-485

  Cantón, Rafael ^a   Ruiz Garbajosa, Patricia ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CARBAPENEM; CEFTRIAXONE; CEPHALOSPORIN; CHLORTETRACYCLINE; FOSFOMYCIN; IMIPENEM; METHYLTRANSFERASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFADIMIDINE; SULFONAMIDE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; GENE LOCUS; GENE MUTATION; GENE TRANSFER; GENETIC SELECTION; MOLECULAR CLONING; MUTATION RATE; NONHUMAN; PLEIOTROPY; PREVALENCE; PRIORITY JOURNAL; RESISTANCE GENE;

EID: 80053115877     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.07.007     Document Type: Review

References (63)

1. E.J. Goldstein Beyond the target pathogen: ecological effects of the hospital formulary Curr Opin Infect Dis 24 Suppl. 1 2011 S21 S31
2. R. Sykes The 2009 Garrod lecture: the evolution of antimicrobial resistance: a Darwinian perspective J Antimicrob Chemother 65 2010 1842 1852
3. S. Pournaras, A. Poulou, E. Voulgari, G. Vrioni, I. Kristo, and A. Tsakris Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae J Antimicrob Chemother 65 2010 1604 1607
4. A.R. Freitas, T.M. Coque, C. Novais, A.M. Hammerum, C.H. Lester, M.J. Zervos, S. Donabedian, L.B. Jensen, M.V. Francia, F. Baquero, and L. Peixe Human and swine hosts share vancomycin-resistant Enterococcus faecium CC17 and CC5 and Enterococcus faecalis CC2 clonal clusters harboring Tn1546 on indistinguishable plasmids J Clin Microbiol 49 2011 925 931
5. R. Cantón, T.M. Coque, and F. Baquero Multi-resistant Gram-negative bacilli: from epidemics to endemics Curr Opin Infect Dis 16 2003 315 325 (Pubitemid 36936670)
6. A.M. Bal, A. Kumar, and I.M. Gould Antibiotic heterogeneity: from concept to practice Ann N Y Acad Sci 1213 2010 81 91
7. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B et al.: Multidrug resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2011, in press, May 7, doi:10.1111/j.1469- 0691.2011.03570.x [Epub ahead of print].
8. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, L.B. Rice, M. Scheld, B. Spellberg, and J. Bartlett Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 2009 1 12
9. L.G. Winston, and H.F. Chambers Antimicrobial resistance in staphylococci: mechanisms of resistance and clinical implications D.L. Mayers, Antimicrobial Drug Resistance. Clinical and Epidemiological Aspects vol. 2 2009 Humana Press New York 735 748
10. D.M. Livermore Of Pseudomonas, porins, pumps and carbapenems J Antimicrob Chemother 47 2001 247 250 (Pubitemid 32229565)
11. K.S. Long, J. Poehlsgaard, C. Kehrenberg, S. Schwarz, and B. Vester The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics Antimicrob Agents Chemother 50 2006 2500 2505 (Pubitemid 43993192)
12. F. Baquero, and M.C. Negri Selective compartments for resistant microorganisms in antibiotic gradients Bioessays 19 1997 731 736 (Pubitemid 27354094)
13. R. Cantón, and M.I. Morosini Emergence and spread of antibiotic resistance following exposure to antibiotics FEMS Microbiol Rev 35 2011 977 991
14. J.W. Mouton, P.G. Ambrose, R. Canton, G.L. Drusano, S. Harbarth, A. MacGowan, U. Theuretzbacher, and J. Turnidge Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective Drug Resist Updat 14 2011 107 117
15. F. Baquero, T.M. Coque, and R. Cantón Antibiotics, complexity, and evolution ASM News 69 2003 547 552
16. M. Sundqvist, P. Geli, D.I. Andersson, M. Sjölund-Karlsson, A. Runehagen, H. Cars, K. Abelson-Storby, O. Cars, and G. Kahlmeter Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use J Antimicrob Chemother 65 2010 350 360
17. R. Cantón Antibiotic resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting Clin Microbiol Infect 15 Suppl. 1 2009 20 25
18. C. Alvarez-Ortega, I. Wiegand, J. Olivares, R.E. Hancock, and J.L. Martínez Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to β-lactam antibiotics Antimicrob Agents Chemother 54 2010 4159 4167
19. H.K. Allen, K.A. Cloud-Hansen, J.M. Wolinski, C. Guan, S. Greene, S. Lu, M. Boeyink, N.A. Broderick, K.F. Raffa, and J. Handelsman Resident microbiota of the gypsy moth midgut harbors antibiotic resistance determinants DNA Cell Biol 28 2009 109 117
20. R. Lamendella, J.W. Santo Domingo, S. Ghosh, J. Martinson, and D.B. Oerther Comparative fecal metagenomics unveils unique functional capacity of the swine gut BMC Microbiol 11 2011 103
21. P.L. Ho, W.U. Lo, M.K. Yeung, C.H. Lin, K.H. Chow, I. Ang, A.H. Tong, J.Y. Bao, S. Lok, and J.Y. Lo Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong PLoS ONE 6 2011 e17989
22. ampC, and insertion sequences IS26 and orf513: an evolutionary phenomenon of recent concern for antibiotic resistance J Clin Microbiol 48 2011 1833 1838
23. G. Cambray, A.M. Guerout, and D. Mazel Integrons Annu Rev Genet 44 2010 141 166
24. M.R. Gillings, M.P. Holley, and H.W. Stokes Evidence for dynamic exchange of qac gene cassettes between class 1 integrons and other integrons in freshwater biofilms FEMS Microbiol Lett 296 2009 282 288
25. TEM-containing transposons in commensal Escherichia coli J Antimicrob Chemother 66 2011 7457 7551
26. Y. Deng, Z. Zeng, S. Chen, L. He, Y. Liu, C. Wu, Z. Chen, Q. Yao, J. Hou, T. Yang, and J.H. Liu Dissemination of IncFII plasmids carrying rmtB and qepA in Escherichia coli from pigs, farm workers and the environment Clin Microbiol Infect 2011 Jan 24, doi:10.1111/j.1469-0691.2011.03472.x [Epub ahead of print]
27. F.E. Dawes, A. Kuzevski, K.A. Bettelheim, M.A. Hornitzky, S.P. Djordjevic, and M.J. Walker Distribution of class 1 integrons with IS26-mediated deletions in their 3′-conserved segments in Escherichia coli of human and animal origin PLoS ONE 5 2010 e12754
28. T. Curiao, R. Cantón, M.P. Garcillán-Barcia, F. de la Cruz, F. Baquero, and T.M. Coque Association of composite IS26-sul3 elements with highly transmissible IncI1 plasmids in extended-spectrum-beta-lactamase- producing Escherichia coli clones from humans Antimicrob Agents Chemother 55 2011 2451 2457
29. R.B. Wu, T.W. Alexander, J.Q. Li, K. Munns, R. Sharma, and T.A. McAllister Prevalence and diversity of class 1 integrons and resistance genes in antimicrobial-resistant Escherichia coli originating from beef cattle administered subtherapeutic antimicrobials J Appl Microbiol 111 2011 511 523 [Epub ahead of print]
30. M. García-Castillo, R. Del Campo, M.I. Morosini, E. Riera, G. Cabot, R. Willems, R. van Mansfeld, A. Oliver, and R. Cantón Wide dispersion of ST175 clone despite a high genetic diversity of carbapenem-non-susceptible Pseudomonas aeruginosa clinical strains from 16 Spanish hospitals J Clin Microbiol 49 2011 2905 2910 [Epub ahead of print]
31. R.J. Willems, W.P. Hanage, D.E. Bessen, and E.J. Feil Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance FEMS Microbiol Rev 35 2011 872 900 [Epub ahead of print]
32. N. Woodford, J.F. Turton, and D.M. Livermore Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance FEMS Microbiol Rev 35 2011 736 755 [Epub ahead of print]
33. G. Peirano, P.C. Schreckenberger, and J.D. Pitout Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131 Antimicrob Agents Chemother 55 2011 2986 2988
34. E. Mantengoli, F. Luzzaro, P. Pecile, D. Cecconi, A. Cavallo, L. Attala, A. Bartoloni, and G.M. Rossolini Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options Clin Infect Dis 52 2011 690 691
35. Ø. Samuelsen, U. Naseer, S. Tofteland, D.H. Skutlaberg, A. Onken, R. Hjetland, A. Sundsfjord, and C.G. Giske Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden J Antimicrob Chemother 63 2009 654 658
36. P. Giakkoupi, C.C. Papagiannitsis, V. Miriagou, O. Pappa, M. Polemis, K. Tryfinopoulou, L.S. Tzouvelekis, and A.C. Vatopoulos An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10) J Antimicrob Chemother 66 2011 1510 1513
37. P. Cholley, M. Thouverez, D. Hocquet, N. van der Mee-Marquet, D. Talon, and X. Bertrand Most Multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in Eastern France belong to a few clonal types J Clin Microbiol 49 2011 2578 2583
38. P. Ruiz-Garbajosa, M.J. Bonten, D.A. Robinson, J. Top, S.R. Nallapareddy, C. Torres, T.M. Coque, R. Cantón, F. Baquero, and B.E. Murray Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination J Clin Microbiol 44 2006 2220 2228 (Pubitemid 43902179)
39. J.A. Otter, and G.L. French Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe Lancet Infect Dis 10 2010 227 239
40. L. Armand-Lefevre, C. Buke, E. Ruppe, F. Barbier, I. Lolom, A. Andremont, R. Ruimy, and J.C. Lucet Secular trends and dynamics of hospital associated methicillin-resistant Staphylococcus aureus Clin Microbiol Infect 16 2010 1435 1441
41. A. Vindel, O. Cuevas, E. Cercenado, C. Marcos, V. Bautista, C. Castellares, P. Trincado, T. Boquete, M. Pérez-Vázquez, and M. Marín Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods J Clin Microbiol 47 2009 1620 1627
42. J.H. Song, P.R. Hsueh, D.R. Chung, K.S. Ko, C.I. Kang, K.R. Peck, J.S. Yeom, S.W. Kim, H.H. Chang, and Y.S. Kim Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study J Antimicrob Chemother 66 2011 1061 1069
43. K.A. Nichol, H.J. Adam, Z. Hussain, M.R. Mulvey, M. McCracken, L.F. Mataseje, K. Thompson, S. Kost, P.R. Lagacé-Wiens, and D.J. Hoban Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study Diagn Microbiol Infect Dis 69 2011 320 325
44. M.A. Argudín, B.A. Tenhagen, A. Fetsch, J. Sachsenröder, A. Käsbohrer, A. Schroeter, J.A. Hammerl, S. Hertwig, R. Helmuth, and J. Bräunig Virulence and resistance determinants of German Staphylococcus aureus ST398 isolates from nonhuman sources Appl Environ Microbiol 77 2011 3052 3060
45. K. Kadlec, C.F. Pomba, N. Couto, and S. Schwarz Small plasmids carrying vga(A) or vga(C) genes mediate resistance to lincosamides, pleuromutilins and streptogramin A antibiotics in methicillin-resistant Staphylococcus aureus ST398 from swine J Antimicrob Chemother 65 2010 2692 2693
46. H. Graveland, J.A. Wagenaar, H. Heesterbeek, D. Mevius, E. van Duijkeren, and D. Heederik Methicillin resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene PLoS ONE 5 2010 e10990
47. E. Meyer, F. Schwab, B. Schroeren-Boersch, and P. Gastmeier Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008 Crit Care 14 2010 R113
48. K. Hussein, H. Sprecher, T. Mashiach, I. Oren, I. Kassis, and R. Finkelstein Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns Infect Control Hosp Epidemiol 30 2009 666 671
49. G.L. Daikos, E. Vryonis, M. Psichogiou, L.S. Tzouvelekis, S. Liatis, P. Petrikkos, C. Kosmidis, P.T. Tassios, G. Bamias, and A. Skoutelis Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase J Antimicrob Chemother 65 2010 784 788
50. D.M. Livermore, M. Warner, S. Mushtaq, M. Doumith, J. Zhang, and N. Woodford What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline Int J Antimicrob Agents 37 2011 415 419
51. D.I. Andersson, and D. Hughes Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8 2010 260 271
52. L.L. Marcusson, N. Frimodt-Møller, and D. Hughes Interplay in the selection of fluoroquinolone resistance and bacterial fitness PLoS Pathog 5 2009 e1000541
53. H. Ward, G.G. Perron, and R.C. Maclean The cost of multiple drug resistance in Pseudomonas aeruginosa J Evol Biol 22 2009 997 1003
54. V.W. Soo, P. Hanson-Manful, and W.M. Patrick Artificial gene amplification reveals an abundance of promiscuous resistance determinants in Escherichia coli Proc Natl Acad Sci USA 108 2011 1484 1489
55. M. García-Castillo, R. del Campo, F. Baquero, M.I. Morosini, M.C. Turrientes, J. Zamora, and R. Cantón Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients Clin Microbiol Infect 17 2011 704 711
56. G.G. Perron, A.R. Hall, and A. Buckling Hypermutability and compensatory adaptation in antibiotic-resistant bacteria Am Nat 176 2010 303 311
57. R.E. Beardmore, and R. Pena-Miller Antibiotic cycling versus mixing: the difficulty of using mathematical models to definitively quantify their relative merits Math Biosci Eng 7 2010 923 933
58. C.T. Bergstrom, M. Lo, and M. Lipsitch Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals Proc Natl Acad Sci USA 101 2004 13285 13290 (Pubitemid 39209657)
59. S. Nijssen, A. Fluit, D. van de Vijver, J. Top, R. Willems, and M.J. Bonten Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant Gram-negative bacteria Intensive Care Med 36 2010 512 519
60. J.A. Martínez, E. Delgado, S. Martí, F. Marco, J. Vila, J. Mensa, A. Torres, C. Codina, A. Trilla, and A. Soriano Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients Intensive Care Med 35 2009 439 447
61. A. Louie, C. Grasso, N. Bahniuk, B. Van Scoy, D.L. Brown, R. Kulawy, and G.L. Drusano The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression Antimicrob Agents Chemother 54 2010 2646 2654
62. V. Plasencia, N. Borrell, M.D. Maciá, B. Moya, J.L. Pérez, and A. Oliver Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents Antimicrob Agents Chemother 51 2007 pp. 2574-1581
63. A. Rodríguez-Rojas, M.D. Maciá, A. Couce, C. Gómez, A. Castañeda-García, A. Oliver, and J. Blázquez Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections PLoS ONE 5 2010 e10193